John Lunger

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
26 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
John Lunger's trades of Adaptimmune Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
84.13
Quantity 85,491
Value US$1,188,407
Transaction date
Proposed sale
Price
133.75
Quantity 30,767
Value US$3,197,045
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-17 2025-01-17
PrS Proposed sale
85,491
84.13
US$1,188,407 		85,491 84.13 US$1,188,407
2025-01-17 2025-01-17
S Sale
58,890 -17.5%
168.47
US$2,984,742 		58,890 -17.5% 168.47 US$2,984,742
2025-01-15 2025-01-15
PrS Proposed sale
30,767
133.75
US$3,197,045 		30,767 133.75 US$3,197,045
2025-01-15 2025-01-15
S Sale
9,803 -41.6%
0.57
US$5,635 		9,803 -41.6% 0.57 US$5,635
2025-01-15 2025-01-13
PrS Proposed sale
9,739
0.59
US$5,726 		9,739 0.59 US$5,726
2025-01-15 2025-01-13
S Sale
5,471 -41.8%
0.59
US$3,216 		5,471 -41.8% 0.59 US$3,216
2025-01-15 2025-01-13
S Sale
4,268 -42.2%
0.59
US$2,509 		4,268 -42.2% 0.59 US$2,509
2024-01-17 2024-01-17
S Sale
12,805 -40.2%
0.67
US$8,618 		12,805 -40.2% 0.67 US$8,618
2024-01-17 2024-01-17
S Sale
5,309 -40.5%
0.67
US$3,573 		5,309 -40.5% 0.67 US$3,573
2024-01-17 2024-01-16
S Sale
4,681 -40.0%
0.79
US$3,698 		4,681 -40.0% 0.79 US$3,698
2024-01-12 2024-01-12
S Sale
5,220 -39.9%
0.85
US$4,458 		5,220 -39.9% 0.85 US$4,458
2024-01-12 2024-01-11
S Sale
4,009 -39.6%
0.84
US$3,354 		4,009 -39.6% 0.84 US$3,354
2023-08-01 2023-08-01
S Sale
3,096 -39.6%
0.91
US$2,804 		3,096 -39.6% 0.91 US$2,804
2023-01-17 2023-01-17
S Sale
4,440 -37.9%
1.86
US$8,250 		4,440 -37.9% 1.86 US$8,250
2023-01-12 2023-01-12
S Sale
4,973 -38.0%
1.71
US$8,484 		4,973 -38.0% 1.71 US$8,484
2023-01-12 2023-01-11
S Sale
3,843 -38.0%
1.75
US$6,713 		3,843 -38.0% 1.75 US$6,713
2023-01-04 2023-01-04
S Sale
1,100 -38.9%
1.69
US$1,863 		1,100 -38.9% 1.69 US$1,863
2022-08-01 2022-08-01
S Sale
2,983 -38.2%
1.77
US$5,290 		2,983 -38.2% 1.77 US$5,290
2022-07-05 2022-07-05
S Sale
1,973 -38.9%
1.68
US$3,311 		1,973 -38.9% 1.68 US$3,311
2022-01-18 2022-01-18
S Sale
4,368 -37.3%
3.19
US$13,942 		4,368 -37.3% 3.19 US$13,942
2022-01-13 2022-01-12
S Sale
1,076 -38.1%
3.54
US$3,813 		1,076 -38.1% 3.54 US$3,813
2022-01-13 2022-01-11
S Sale
3,770 -37.3%
3.56
US$13,409 		3,770 -37.3% 3.56 US$13,409
2022-01-05 2022-01-04
S Sale
1,070 -37.9%
4.06
US$4,349 		1,070 -37.9% 4.06 US$4,349
2021-01-19 2021-01-19
S Sale
4,358 -37.2%
5.67
US$24,708 		4,358 -37.2% 5.67 US$24,708
2021-01-12 2021-01-12
S Sale
1,058 -37.5%
6.15
US$6,509 		1,058 -37.5% 6.15 US$6,509
2021-01-05 2021-01-04
S Sale
1,065 -37.7%
5.33
US$5,674 		1,065 -37.7% 5.33 US$5,674
2020-08-04 2020-08-03
S Sale
4,823 -37.4%
9.25
US$44,613 		4,823 -37.4% 9.25 US$44,613
2020-01-15 2020-01-14
S Sale
1,144 -40.5%
5.13
US$5,874 		1,144 -40.5% 5.13 US$5,874
2020-01-07 2020-01-06
S Sale
1,148 -40.6%
1.20
US$1,378 		1,148 -40.6% 1.20 US$1,378